Targeting of the STAT3 pathway is a crucial point, as activation leads to increased production of vascular endothelial growth factor (VEGF), an angiogenic factor important for tumour development, invasion, and metastasis [15, 43]. This evidence concerns the gene STAT3 and neoplasm.